R&D

Merck invests over €300m in new life science research center in Germany

Merck is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector will...

View the Online Magazine

Latest Issue

Magazine Archive

Launches

Beckman Coulter’s DxI 9000 Immunoassay Analyzer extends menu with new CE-marked hepatitis assays at ESCMID Global

Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases...

Getinge and CellRev launch pioneering adherent cell expansion platform

CellRev, in partnership with Getinge, has launched a breakthrough adherent cell expansion platform, Livit ACE. Designed to eliminate many of the limitations and inefficiencies associated...

Data on over 2,300 lung cancer biomarkers mapped in new global database

A new database has been created to support pharmaceutical and biotech companies in the creation of new drugs to treat lung cancer, bringing the...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year

ACG, the world’s largest integrated supplier and service provider to the pharmaceutical industry, is delighted to announce that for the fourth consecutive year, it...

Emergent BioSolutions receives $75m contract option from BARDA to procure doses of anthrax vaccine

The Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response at the United States Department of Health and...

UK Health Security Agency agrees vaccine deal

The UK Health Security Agency (UKHSA) has agreed a deal for millions of life-saving vaccines to be produced in the UK if a future...

Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK

A. Menarini Farmaceutica Internazionale SRL (Menarini) has become the exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (a fixed-dose combination of canagliflozin and metformin) in the United...

Approvals

Manufacturiung

Finance

Research & Development
Latest

R&D

Merck invests over €300m in new life science research center in Germany

Merck is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the...
R&D

New research centre to improve tests and treatments for rare lung diseases

A £9.4 million collaborative research centre will accelerate improved tests, treatments and potentially cures for thousands of people living with rare respiratory diseases. The LifeArc...
R&D

Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin)

Mundipharma has acquired all assets and rights related to rezafungin globally from Cidara Therapeutics. This provides Mundipharma with global ownership of rezafungin including ongoing development...
R&D

Ipsen and Skyhawk Therapeutics form RNA targeting research collaboration in rare neurological diseases

Ipsen and Skyhawk Therapeutics have signed an exclusive worldwide collaboration to discover and develop novel small molecules that modulate RNA for rare neurological diseases. The...
R&D

Ochre Bio and Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease

Ochre Bio has formed a partnership with Boehringer Ingelheim focused on the discovery and development of novel, first-in-class regenerative treatments for chronic liver diseases (CLDs),...

Appointments

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks